Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

为了解决这一问题，来自瑞典乌普萨拉大学（Uppsala University）和瑞士美敦力公司（Medtronic）等机构的研究人员展开了一项 ... 研究结果显示，在 20 年的时间跨度内，深部脑刺激（deep brain stimulation，DBS）联合最佳药物治疗（best medical therapy，BMT）是最具成本效益 ...

Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology, introducing aDBS for people living with Parkinson's. This feature personalizes ...

Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology†, introducing aDBS for people living with Parkinson's. This feature personalizes ...

Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease. The approval is for BrainSense Adaptive deep brain stimulation (DBS)and BrainSense ...

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever GALWAY, Ireland, Feb. 24, 2025 ...

Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no cure for debilitating neurological conditions ...

Now Medtronic has enhanced its Percept DBS neurostimulators with exclusive BrainSense Adaptive technology †, introducing aDBS for people living with Parkinson's. This feature personalizes ...

On Monday, the FDA approved Medtronic plc’s (NYSE:MDT) BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s disease.